Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...

Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular ...

A new report finds that a majority of Americans think the U.S. should be a world leader in science, but Democrats ...

At the WCI Summit in November, researchers shared some of the novel techniques that they are using to improve the human ...

For decades, television advertising has been a game of creativity and repetition. Jingles and mascots became part of our ...

Scientific uncertainty persists around 3I/ATLAS after anomalous observations and a CIA FOIA response, despite NASA’s public ...

Wikipedia had to fight to establish its legitimacy—and now it faces a new existential threat posed by generative AI ...

Republicans and Democrats agree that it’s important the U.S. is a world leader in science, but sharply diverge on how the U.S ...